Spotify Apple Youtube

Category: NAIL-NIT

All Podcast Categories
S3-E62.1 - Year-End Interview with Mazen Noureddin

S3-E62.1 – Year-End Interview with Mazen Noureddin

Surfing the NASH Tsunami hosts its Season 3 finale to celebrate a momentous year in Fatty Liver through a series of interviews with Key Opinion Leaders. For this second installment, Surfers Jörn Schattenberg, Louise Campbell and Roger Green are joined by Mazen Noureddin to reflect on opening a new research institute, increasing optimism around drug trials and the use of NITs, work in the novel mitochondrial uncoupling agent HU6, the NAIL-NIT consortium and more.

December 28, 2022
S3-E58 - Surfing 2022: NAFLD Year-in-Review

S3-E58 – Surfing 2022: NAFLD Year-in-Review

Surfing the NASH Tsunami hosts its third NAFLD Year-in-Review – our look at key highlights of 2022 featuring the impressions of Jörn Schattenberg, Louise Campbell and Roger Green. This discussion looks at the return to in-person conferences and events, NICE on FibroScan, progress in NITs, potential pathway developments and much more.

December 8, 2022
S3-E45.4 - Paris Review: NITs, Metabolic Disease and Final Thoughts

S3-E45.4 – Paris Review: NITs, Metabolic Disease and Final Thoughts

In a review of Paris NASH 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by patient advocate, Jeff McIntyre. In this final conversation, the group explores the rest of the Day Two program, focusing on the development of an NIT diagnostic pathway. Finally, each offers their closing remarks on being a part of the 8th Paris NASH Meeting and what the future looks like in this space.

September 20, 2022
S3-E45.3 - Paris Review: Session 5 on Clinical Trial Innovation

S3-E45.3 – Paris Review: Session 5 on Clinical Trial Innovation

In a review of Paris NASH 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by patient advocate, Jeff McIntyre. In this conversation, the group discusses presentations on adaptive trial strategies, trial recruitment and reducing screen fail rates, and the impact of educating patients on better self-care.

September 20, 2022
S3-E43 - Combination Agents: A Cornerstone Of Future NASH Therapy?

S3-E43 – Combination Agents: A Cornerstone Of Future NASH Therapy?

Naim Alkhouri and Mazen Noureddin join the Surfers to discuss the future role of Combination Agents with NASH therapy, stemming from their recently published article, Safety and efficacy of combination therapy with semaglutide,cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial (JHEP, 2022). The conversation focuses more broadly on the benefits and future of combination therapies for NASH patients.

September 1, 2022
S3-E38.5 - From the Vault: NAIL-NIT tackles NAS Score Challenges

S3-E38.5 – From the Vault: NAIL-NIT tackles NAS Score Challenges

From February of this year, Stephen Harrison and Mazen Noureddin join Jörn Schattenberg, Louise Campbell and Roger Green to discuss the formation of the new NAIL-NIT consortium, led by Stephen and Mazen. This conversation focuses on the specific challenges inherent in the NAS scores.

July 30, 2022
Stay In Touch
Apple Spotify Youtube

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.

Learn More